Lymphadenopathy screening: Difference between revisions

	Lymphadenopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphadenopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphadenopathy screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphadenopathy screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphadenopathy screening
CDC on Lymphadenopathy screening
Lymphadenopathy screening in the news
Blogs on Lymphadenopathy screening
Directions to Hospitals Treating Lymphadenopathy
Risk calculators and risk factors for Lymphadenopathy screening

Revision as of 17:52, 24 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

There is insufficient evidence to recommend routine screening for lymphadenopathy

There is insufficient evidence to recommend routine screening for lymphadenopathy

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Xyz}}
+{{Lymphadenopathy}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}} {{ADS}}
 ==Overview==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
+There is insufficient evidence to recommend routine screening for lymphadenopathy
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
 ==Screening==
-There is insufficient evidence to recommend routine screening for [disease/malignancy].
+*There is insufficient evidence to recommend routine screening for lymphadenopathy
-OR
-According to the [guideline name], screening for [disease name] is not recommended.
-OR
-According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-*[Condition 1]
-*[Condition 2]
-*[Condition 3]
 ==References==
 {{Reflist|2}}
+[[Category:Medicine]]
+[[Category:Oncology]]
+[[Category:Up-To-Date]]
+[[Category:Primary care]]
+[[Category:Surgery]]
 {{WH}}
 {{WS}}